Merete Lund Hetland

Merete Lund Hetland

Clinical Professor

Member of:

  • Internal Medicine: Rheumatology


Publication year:
All
71 - 80 out of 454Page size: 10
  1. 2022
  2. Published

    The Programmed Death-1 Pathway Counter-Regulates Inflammation-Induced Osteoclast Activity in Clinical and Experimental Settings

    Greisen, S. R., Kragstrup, T. W., Thomsen, J. S., Hørslev-Pedersen, K., Hetland, Merete Lund, Stengaard-Pedersen, K., Østergaard, Mikkel, Ørnbjerg, L., Junker, P., Sharpe, A. H., Freeman, G. J., Hvid, M., Moestrup, S. K., Hauge, E. M. & Deleuran, B., 2022, In: Frontiers in Immunology. 13, 773946.

    Research output: Contribution to journal › Journal article › Research › peer-review

  3. Published

    The impact of a csDMARD in combination with a TNF inhibitor on drug retention and clinical remission in axial spondyloarthritis

    Nissen, M., Delcoigne, B., Di Giuseppe, D., Jacobsson, L., Hetland, M. L., Ciurea, A., Nekvindova, L., Iannone, F., Akkoc, N., Sokka-Isler, T., Fagerli, K. M., Santos, M. J., Codreanu, C., Pombo-Suarez, M., Rotar, Z., Gudbjornsson, B., van der Horst-Bruinsma, I., Loft, A. G., Möller, B., Mann, H. & 12 others, Conti, F., Yildirim Cetin, G., Relas, H., Michelsen, B., Avila Ribeiro, P., Ionescu, R., Sanchez-Piedra, C., Tomsic, M., Geirsson, Á. J., Askling, J., Glintborg, Bente & Lindström, U., 2022, In: Rheumatology. 61, 12, p. 4741-4751 11 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  4. Published

    The occurrence of multiple treatment switches in axial spondyloarthritis. Results from five Nordic rheumatology registries

    Di Giuseppe, D., Lindström, U., Aaltonen, K., Relas, H., Provan, S., Gudbjornsson, B., Hetland, Merete Lund, Askling, J., Kauppi, M., Geirsson, A. J., Chatzidionysiou, K., Jørgensen, T. S., Dreyer, L., Michelsen, B., Jacobsson, L. & Glintborg, Bente, 2022, In: Rheumatology. 61, 9, p. 3647-3656 10 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  5. 2021
  6. Published

    Doppler ultrasound predicts successful discontinuation of biological DMARDs in rheumatoid arthritis patients in clinical remission

    Terslev, L., Brahe, C. H., Hetland, M. L., Georgiadis, S., Ellegaard, K., Juul, L., Huynh, T., Døhn, U. M., Fana, V., Møller, T., Krabbe, S., Ørnbjerg, L. M., Glinatsi, D., Røgind, H., Hansen, A., Nørregaard, J., Jacobsen, S., Jensen, D. V., Manilo, N., Asmussen, K. & 6 others, Boesen, Mikael Ploug, Rastiemadabadi, Z., Morsel-Carlsen, L., Møller, J. M., Krogh, N. S. & Østergaard, Mikkel, 1 Dec 2021, In: Rheumatology (United Kingdom). 60, 12, p. 5549-5559 11 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  7. Published

    Similar lipid level changes in early rheumatoid arthritis patients following 1-year treat-to-target strategy with adalimumab plus methotrexate versus placebo plus methotrexate: secondary analyses from the randomised controlled OPERA trial

    Mašić, D., Stengaard-Pedersen, K., Løgstrup, B. B., Hørslev-Petersen, K., Hetland, Merete Lund, Junker, P., Østergaard, Mikkel, Ammitzbøll, C., Møller, Søren, Christensen, R. & Ellingsen, T., Mar 2021, In: Rheumatology International. 41, 3, p. 543-549 7 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  8. Published

    Anxiety and concerns related to the work situation during the second wave of the COVID-19 pandemic in >5000 patients with inflammatory rheumatic disease followed in the DANBIO registry

    Glintborg, B., Jensen, D. V., Engel, S., Terslev, L., Pfeiffer Jensen, M., Hendricks, O., Østergaard, M., Horskjær Rasmussen, S., Adelsten, T., Colic, A., Danebod, K., Kildemand, M., Loft, A. G., Munk, H. L., Pedersen, J. K., Østgård, R. D., Møller Sørensen, C., Krogh, N. S., Nørgaard Agerbo, J., Ziegler, C. & 1 others, Hetland, Merete Lund, 2021, In: RMD Open. 7, 2, e001649.

    Research output: Contribution to journal › Journal article › Research › peer-review

  9. Published

    Comparative effectiveness of two adalimumab biosimilars in 1318 real-world patients with inflammatory rheumatic disease mandated to switch from originator adalimumab: Nationwide observational study emulating a randomised clinical trial

    Nabi, H., Georgiadis, S., Loft, A. G., Hendricks, O., Andersen, M., Chrysidis, S., Colic, A., Danebod, K., Hussein, M. R., Kalisz, M. H., Kristensen, S., Lomborg, N., Manilo, N., Munk, H. L., Pedersen, J. K., Raun, J. L., Mehnert, F., Krogh, N. S., Hetland, Merete Lund & Glintborg, Bente, 2021, In: Annals of the Rheumatic Diseases. 80, 11, p. 1400-1409.

    Research output: Contribution to journal › Journal article › Research › peer-review

  10. Published

    Comparison of treatment retention and response to secukinumab versus tumour necrosis factor inhibitors in psoriatic arthritis

    Lindström, U., Glintborg, Bente, Di Giuseppe, D., Schjødt Jørgensen, T., Gudbjornsson, B., Lederballe Grøn, K., Aarrestad Provan, S., Michelsen, B., Hetland, Merete Lund, Wallman, J. K., Nordström, D., Trokovic, N., Love, T. J., Krogh, N. S., Askling, J., Jacobsson, L. T. H. & Kristensen, Lars Erik Vølund, 2021, In: Rheumatology (Oxford, England). 60, 8, p. 3635-3645 11 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  11. Published

    Considerations and priorities for incorporating the patient perspective on remission in rheumatoid arthritis: An OMERACT 2020 special interest group report

    Jones, B., Flurey, C. A., Proudman, S., Ferreira, R. J. O., Voshaar, M., Hoogland, W., Chaplin, H., Goel, N., Hetland, M. L., Hill, C., Kuriya, B., Mather, K., Rasch, L., Shea, B., Singh, J. A., Smolen, J. S., da Silva, J. AP., de Souza, S., Stamm, T., Studenic, P. & 3 others, de Wit, M., Tugwell, P. & Boers, M., 2021, In: Seminars in Arthritis and Rheumatism. 51, 5, p. 1108-1112

    Research output: Contribution to journal › Journal article › Research › peer-review

  12. Published

    Effectiveness of a second biologic after failure of a non–tumor necrosis factor inhibitor as first biologic in rheumatoid arthritis

    Chatzidionysiou, K., Hetland, Merete Lund, Frisell, T., Di Giuseppe, D., Hellgren, K., Glintborg, Bente, Nordström, D., Peltomaa, R., Aaltonen, K., Trokovic, N., Kristianslund, E. K., Kvien, T. K., Provan, S. A., Gudbjornsson, B., Grondal, G., Dreyer, L., Kristensen, Lars Erik Vølund, Jørgensen, T. S., Jacobsson, L. T. H. & Askling, J., 2021, In: Journal of Rheumatology. 48, 10, p. 1512-1518 7 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

Previous 1...4 5 6 7 8 9 10 11 ...46 Next

ID: 922207